Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Aceragen Inc. buy melinda

Start price
€229.40
05.02.18 / 50%
Target price
€267.42
19.03.18
Performance (%)
3.21%
End price
€236.76
19.03.18
Summary
This prediction ended on 19.03.18 with a price of €236.76. The BUY prediction by melinda finished with a performance of 3.21%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Aceragen Inc. - - - -
iShares Core DAX® 4.094% 3.543% 17.404% 20.326%
iShares Nasdaq 100 1.424% 0.512% 39.212% 55.365%
iShares Nikkei 225® -1.572% -4.633% 15.731% 2.146%
iShares S&P 500 1.822% 0.963% 30.396% 45.950%

According to melinda what are the pros and cons of Aceragen Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Idera Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 3.21%
Target price 15.731
Change
Ends at 19.03.18

Biotechnologie und medizinische SecteurRecherche



Beruf
Logo Idera Pharmaceuticals Inc
Die Entdeckung und neue therapeutische für Nukleinsäuren zu entwickeln

Idera Pharmaceuticals, Inc. ist ein in der klinischen Biotechnologie - Unternehmen , das sich auf die Entdeckung, Entwicklung und Vermarktung neuartiger Therapeutika auf Basis Oligonukleotide für die Onkologie und seltene Krankheiten.

Das Unternehmen arbeitet mit zwei verschiedenen Technologieplattformen für die Wirkstoffforschung zu entwerfen und zu Wirkstoffkandidaten zu entwickeln: Targeting - Technologie von Toll-like - Rezeptoren und die dritte Generation Antisense - Technologie.

Das Unternehmen wurde von Paul C. Zamecnik, Sudhir Agrawal A. und James B. Wyngaarden Mai 1989 25, gegründet und ist in Cambridge, MA ansässig.

Anzahl der Mitarbeiter: 62 Personen.



Prediction Buy
Perf. (%) 3.21%
Target price 15.731
Change
Ends at 19.03.18

(Vom Mitglied beendet)

Stopped prediction by melinda for Aceragen Inc.

buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€1.52
02.05.23
€3.00
02.05.24
-70.66%
13.02.24

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€8.06
29.03.22
€15.30
29.03.23
-17.24%
30.03.23

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€31.11
01.10.20
€59.50
04.11.21
-60.11%
05.11.21

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€31.79
15.11.19
-
01.10.20
-2.14%
01.10.20

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€56.28
03.05.19
€107.34
30.10.19
-28.10%
30.10.19

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€41.40
24.03.19
€53.67
03.05.19
30.37%
03.05.19

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€154.57
29.06.18
€226.94
10.07.18
5.56%
10.07.18

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€251.60
09.11.17
€544.00
29.11.17
24.32%
29.11.17

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€226.94
09.11.17
€490.69
29.11.17
24.32%
29.11.17

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€226.94
11.05.17
€269.88
11.09.17
23.48%
11.09.17

Could be worthwhile Investment >10% per year
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€276.01
15.04.17
€306.68
26.04.17
12.00%
26.04.17

Could be worthwhile Investment >10% per year
Aceragen Inc.

Start price
Target price
Perf. (%)
€299.20
04.10.13
€272.00
24.02.14
100.00%
24.02.14

Could be worthwhile Investment >10% per year